Serum levels of vascular endothelial growth factor in patients undergoing prostate biopsy for suspicion of prostate cancer

Urology

Volumn 66, Issue 3, 2005, Pages 687-691

  Peyromaure, Michaël ^a   Goulvestre, Claire ^a   Fulla, Yvonne ^a   Grabar, Sophie ^a   Debré, Bernard ^a   Dinh Xuan, Anh Tuan ^a  

^a Cochin Hospital ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; VASCULOTROPIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

AGED; BIOPSY; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 24144482706     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2005.03.082     Document Type: Article

References (10)

1. L.F. Brown, K.T. Yeo, B. Berse Vascular permeability factor (vascular endothelial growth factor) is strongly expressed in the normal male genital tract and is present in substantial quantities in semen J Urol 154 1995 576 579
2. D. Stefanou, A. Batistatou, S. Kamina Expression of vascular endothelial growth factor and association with microvessel density in benign prostatic hyperplasia and prostate cancer In Vivo 18 2004 155 160
3. R. Li, M. Younes, T.M. Wheeler Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate Prostate 58 2004 193 199
4. J. Picus, S. Halabi, B. Rini The use of bevacizumab (B) with docetaxel (D) and estramustine (E) in hormone refractory prostate cancer (HRPC) initial results of CALGB 90006 abstract Proc Am Soc Clin Oncol 22 2003 393
5. J.L. Duque, K.R. Loughlin, R.M. Adam Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer Urology 54 1999 523 527
6. S.F. Shariat, V.A. Anwuri, D.J. Lamb Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy J Clin Oncol 22 2004 1655 1663
7. C.C. Lin, H.C. Wu, F.J. Tsai Vascular endothelial growth factor gene -460 C/T polymorphism is a biomarker for prostate cancer Urology 62 2003 374 377
8. R.E. Banks, M.A. Forbes, S.E. Kinsey Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets significance for VEGF measurements and cancer biology Br J Cancer 77 1998 956 964
9. W.J. Catalona, D.S. Smith, D.K. Ornstein Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements JAMA 277 1997 1452 1455
10. D.J. George, M.M. Regan, W.K. Oh Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer Urology 63 2004 327 332